BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24374199)

  • 1. The endogenous substrates of brain CYP2D.
    Wang X; Li J; Dong G; Yue J
    Eur J Pharmacol; 2014 Feb; 724():211-8. PubMed ID: 24374199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic specificity of CYP2D isoforms in rat and human.
    Hiroi T; Chow T; Imaoka S; Funae Y
    Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional and cellular distribution of CYP2D subfamily members in rat brain.
    Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
    Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone oxidation by cytochrome P450 2D isoforms in the brain.
    Hiroi T; Kishimoto W; Chow T; Imaoka S; Igarashi T; Funae Y
    Endocrinology; 2001 Sep; 142(9):3901-8. PubMed ID: 11517168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities.
    Venhorst J; ter Laak AM; Commandeur JN; Funae Y; Hiroi T; Vermeulen NP
    J Med Chem; 2003 Jan; 46(1):74-86. PubMed ID: 12502361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain.
    Niwa T; Okada K; Hiroi T; Imaoka S; Narimatsu S; Funae Y
    Biol Pharm Bull; 2008 Mar; 31(3):348-51. PubMed ID: 18310890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain.
    Kishimoto W; Hiroi T; Shiraishi M; Osada M; Imaoka S; Kominami S; Igarashi T; Funae Y
    Endocrinology; 2004 Feb; 145(2):699-705. PubMed ID: 14563706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
    Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.
    Tyndale RF; Li Y; Li NY; Messina E; Miksys S; Sellers EM
    Drug Metab Dispos; 1999 Aug; 27(8):924-30. PubMed ID: 10421620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoform-selective metabolism of mianserin by cytochrome P-450 2D.
    Chow T; Hiroi T; Imaoka S; Chiba K; Funae Y
    Drug Metab Dispos; 1999 Oct; 27(10):1200-4. PubMed ID: 10497148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters.
    Anna Haduch A; Bromek E; Daniel WA
    Pharmacol Rep; 2013; 65(6):1519-28. PubMed ID: 24553000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ hybridization study of CYP2D mRNA in the common marmoset brain.
    Shimamoto Y; Niimi K; Kitamura H; Tsubakishita S; Takahashi E
    Exp Anim; 2016 Nov; 65(4):465-471. PubMed ID: 27356856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol.
    Li J; Xie M; Wang X; Ouyang X; Wan Y; Dong G; Yang Z; Yang J; Yue J
    Br J Pharmacol; 2015 Oct; 172(19):4639-54. PubMed ID: 26031356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders.
    Haduch A; Daniel WA
    Drug Metab Rev; 2018 Nov; 50(4):415-429. PubMed ID: 30501426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and effect of para-toluene-sulfonamide on rat liver microsomal cytochrome P450 from in vivo and in vitro studies.
    Zhou JQ; Tang ZQ; Zhang JN; Tang JC
    Acta Pharmacol Sin; 2006 May; 27(5):635-40. PubMed ID: 16626521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.
    Miksys S; Tyndale RF
    Drug Metab Rev; 2004 May; 36(2):313-33. PubMed ID: 15237857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
    Yue J; Miksys S; Hoffmann E; Tyndale RF
    J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
    Haduch A; Bromek E; Daniel WA
    Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain microsomal metabolism of phencyclidine in male and female rats.
    Laurenzana EM; Owens SM
    Brain Res; 1997 May; 756(1-2):256-65. PubMed ID: 9187340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
    Haduch A; Rysz M; Papp M; Daniel WA
    Biochem Pharmacol; 2018 Oct; 156():398-405. PubMed ID: 30195732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.